GO:0150078 positive regulation of neuroinflammatory response: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0150078 describes any process that activates or increases the frequency, rate or extent of the neuroinflammatory response, a central biological process in acute and chronic CNS injury.
• Positive regulation of neuroinflammation is driven by innate immune signaling hubs including TBK1, TAK1, JAK/STAT, TLRs, and NF-kB, which amplify microglial and astrocytic inflammatory programs.
• Dysregulated positive regulation of neuroinflammation contributes to Parkinson's disease, Alzheimer's disease, subarachnoid hemorrhage, and systemic inflammation-associated neuropathology.
• Key genetic and pharmacological studies show that suppressing JAK/STAT, PPARgamma/NF-kB, or S100A9 signaling reduces neuroinflammatory markers and improves outcomes in preclinical models.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to establish causal roles of candidate genes in GO:0150078.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to dissect positive regulation of neuroinflammatory response with publication-grade rigor.
Description
The Gene Ontology term GO:0150078, positive regulation of neuroinflammatory response, refers to any process that activates or increases the frequency, rate or extent of the neuroinflammatory response. Neuroinflammation is a complex biological process executed by resident CNS cells such as microglia and astrocytes, and by infiltrating peripheral immune cells, and it is a hallmark of many neurological disorders. Understanding the positive regulation of this response is critical because excessive or sustained neuroinflammatory signaling can drive neuronal dysfunction and cognitive decline. Mechanistically, positive regulation of neuroinflammatory response is mediated by pattern-recognition receptors, kinases such as TBK1 and TAK1, transcription factors including NF-kB and STAT proteins, and lipid mediators. For example, activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation and neuroinflammation in Parkinson's disease models, while TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage. These findings illustrate how distinct molecular events converge on the same GO term. For researchers, GO:0150078 provides a standardized framework to annotate and compare experimental results across models of neurodegeneration, infection, and sterile CNS injury. It also guides the selection of therapeutic targets and biomarkers aimed at dampening pathological neuroinflammation without compromising protective immunity.
positive regulation of neuroinflammatory response At A Glance
| GO ID | GO:0150078 |
|---|---|
| GO term | positive regulation of neuroinflammatory response |
| Ontology | biological_process |
| Synonym | none |
| Major function | Activation or amplification of neuroinflammatory signaling in the CNS |
| Definition | Any process that activates or increases the frequency, rate or extent of neuroinflammatory response. |
| Related processes | Innate immune activation, cytokine production, glial activation, immune cell recruitment |
| Disease relevance | Parkinson's disease, Alzheimer's disease, subarachnoid hemorrhage, systemic inflammation-associated neuropathology |
| Research methods | CRISPR KO/KI, RNA-seq, proteomics, imaging, pharmacological inhibition |
What Is GO:0150078?
In our own words, GO:0150078 positive regulation of neuroinflammatory response encompasses any molecular or cellular event that increases the intensity, duration, or frequency of the neuroinflammatory response. This includes signaling cascades that activate microglia and astrocytes, upregulate proinflammatory cytokines and chemokines, recruit peripheral immune cells, and sustain inflammatory gene expression in the central nervous system. The term is a biological process child of regulation of neuroinflammatory response and is distinct from the neuroinflammatory response itself.
Why Is positive regulation of neuroinflammatory response Important in Cell Biology?
Positive regulation of neuroinflammatory response is important because it determines whether CNS inflammation resolves or becomes chronic and damaging. Excessive activation of this process is implicated in the pathogenesis of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, as well as acute CNS injuries like subarachnoid hemorrhage. Identifying the genes and pathways that positively regulate neuroinflammation can reveal therapeutic targets and biomarkers, and CRISPR-based models are essential to establish causality.
• Drives microglial and astrocytic activation, a hallmark of neurodegeneration.
• Amplifies proinflammatory cytokine and chemokine production in the CNS.
• Contributes to neuronal pyroptosis and early brain injury after subarachnoid hemorrhage.
• Links systemic inflammation to brain proinflammatory signatures.
• Involved in Parkinson's disease via TBK1-ACSL1 lipid droplet accumulation.
• Modulated by JAK/STAT and PPARgamma/NF-kB pathways, offering druggable nodes.
• Influenced by gut microbiota and tonic type I interferon signaling during CNS infection.
• Genetic variants in TLR signaling components such as UNC93B1 can drive autoimmunity.
• Serves as a convergence point for diverse upstream triggers including myelin sulfatide deficiency.
• Provides a standardized GO annotation for cross-study comparison and meta-analysis.
What Happens During positive regulation of neuroinflammatory response?
Initiation by pattern-recognition receptor signaling
In simple terms: The process often starts when immune sensors on brain cells detect danger signals.
Positive regulation of neuroinflammatory response is frequently initiated by Toll-like receptors (TLRs) and other pattern-recognition receptors that sense pathogens or damage-associated molecules. Genetic analysis of UNC93B1 variants has shown that altered TLR trafficking can drive TLR-mediated autoimmunity in mice and humans, demonstrating how receptor-level events can amplify neuroinflammatory signaling. In the context of CNS infection, gut microbiota can limit systemic inflammation by priming tonic type I interferon signaling, which in turn modulates the neuroinflammatory set point.
Kinase cascade activation: TBK1 and TAK1
In simple terms: Specific enzymes act as switches that turn up the inflammatory response.
Activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation and neuroinflammation in Parkinson's disease, directly linking a kinase to positive regulation of neuroinflammatory response. Similarly, TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage, indicating that TAK1-dependent signaling is a positive regulator of neuroinflammatory cell death pathways. These kinases represent key nodes where pharmacological or genetic intervention can reduce neuroinflammation.
Transcription factor activation: NF-kB and STAT
In simple terms: Transcription factors enter the nucleus and turn on inflammatory genes.
The NF-kB and JAK/STAT pathways are central to the positive regulation of neuroinflammatory response. Chuanxiong Renshen Decoction inhibits Alzheimer's disease neuroinflammation by regulating the PPARgamma/NF-kB pathway, showing that NF-kB activity is a positive regulator of neuroinflammatory gene expression. Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease, confirming that JAK/STAT signaling positively regulates neuroinflammation in vivo.
Lipid mediator and metabolic amplification
In simple terms: Changes in cellular fat metabolism can further boost inflammation.
Lipid droplet accumulation mediated by ACSL1 downstream of TBK1 is a metabolic amplification step in microglia that sustains neuroinflammation in Parkinson's disease models. Additionally, adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment, indicating that lipid composition changes in myelin can positively regulate neuroinflammatory responses.
Systemic-to-CNS propagation
In simple terms: Inflammation in the body can spread signals to the brain.
DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod, demonstrating that peripheral inflammation can positively regulate neuroinflammatory response through soluble mediators such as S100A9. This gut-brain axis highlights how systemic events can activate CNS inflammatory programs.
Key Genes Involved in GO:0150078 positive regulation of neuroinflammatory response
The following genes and proteins have been experimentally linked to positive regulation of neuroinflammatory response in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TBK1 | Kinase that promotes ACSL1-mediated lipid droplet accumulation and neuroinflammation | Target for Parkinson's disease neuroinflammation |
| ACSL1 | Enzyme mediating lipid droplet formation downstream of TBK1 | Metabolic amplifier of microglial neuroinflammation |
| TAK1 | Kinase mediating neuronal pyroptosis in early brain injury | Target in subarachnoid hemorrhage |
| UNC93B1 | TLR trafficking chaperone; variants drive TLR-mediated autoimmunity | Genetic model for autoimmunity and neuroinflammation |
| JAK | Janus kinase upstream of STAT in inflammatory signaling | Pathway inhibition reduces neuroinflammation |
| STAT | Transcription factor downstream of JAK; drives inflammatory gene expression | Target in Parkinson's disease models |
| NF-kB | Transcription factor activating proinflammatory genes | Modulated by PPARgamma in Alzheimer's disease |
| PPARgamma | Nuclear receptor that suppresses NF-kB-driven neuroinflammation | Therapeutic target in Alzheimer's disease |
| S100A9 | Proinflammatory alarmin; inhibitor paquinimod reduces brain inflammation | Link between colon inflammation and brain |
| Type I interferon | Cytokine that primes tonic antiviral signaling and limits systemic inflammation | Modulates neuroinflammatory set point during CNS infection |
| Gut microbiota | Commensal community that primes tonic type I interferon signaling | Environmental regulator of neuroinflammation |
| Sulfatide | Myelin lipid; deficiency causes Alzheimer's-like neuroinflammation | Lipid regulator of neuroinflammation |
| IL-1beta | Proinflammatory cytokine downstream of inflammasome activation | Readout of neuroinflammatory response |
| TNF-alpha | Proinflammatory cytokine produced by activated microglia | Common marker of neuroinflammation |
| IL-6 | Cytokine induced by JAK/STAT signaling | Marker of neuroinflammatory activation |
| CCL2 | Chemokine recruiting monocytes to the CNS | Mediator of neuroinflammatory propagation |
| CXCL10 | Chemokine induced by type I interferon and NF-kB | Marker of neuroinflammatory response |
How Is positive regulation of neuroinflammatory response Regulated?
Positive regulation of neuroinflammatory response is itself tightly regulated at multiple levels. Tonic type I interferon signaling primed by the gut microbiota can limit systemic inflammation during neurotrophic viral CNS infection, indicating that baseline interferon tone sets the threshold for neuroinflammatory activation. The JAK/STAT pathway is a major positive regulator, and its pharmacological suppression inhibits neuroinflammation in Parkinson's disease models. The PPARgamma/NF-kB axis provides another layer: activation of PPARgamma suppresses NF-kB-driven neuroinflammation, as shown in Alzheimer's disease models treated with Chuanxiong Renshen Decoction. Additionally, S100A9 acts as a systemic mediator that can propagate colon inflammation to the brain, and its inhibition by paquinimod ameliorates the brain proinflammatory signature. These examples illustrate that positive regulation of neuroinflammatory response is controlled by a balance of pro- and anti-inflammatory signals.
positive regulation of neuroinflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TBK1 | Parkinson's disease neuroinflammation | Knockout or point-mutation microglia cell lines |
| TAK1 | Subarachnoid hemorrhage early brain injury | Neuronal knockout models |
| UNC93B1 | TLR-mediated autoimmunity | Knock-in mice or human cell lines with variants |
| JAK/STAT | Parkinson's disease neuroinflammation | Pharmacological inhibition and knockout models |
| S100A9 | Colon inflammation-driven brain proinflammatory signature | Knockout mice and inhibitor treatment |
Parkinson's disease
In Parkinson's disease, activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation and neuroinflammation, directly linking GO:0150078 to disease pathogenesis. Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease, further supporting the role of positive regulation of neuroinflammatory response in disease progression.
Alzheimer's disease
Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment, demonstrating that lipid changes can positively regulate neuroinflammation in Alzheimer's disease. Chuanxiong Renshen Decoction inhibits Alzheimer's disease neuroinflammation by regulating the PPARgamma/NF-kB pathway, highlighting a druggable node within GO:0150078.
Subarachnoid hemorrhage and acute brain injury
TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage, identifying TAK1 as a positive regulator of neuroinflammatory cell death in acute CNS injury. This suggests that targeting positive regulation of neuroinflammatory response may reduce secondary brain damage.
Systemic inflammation and gut-brain axis
DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod, showing that peripheral inflammation can positively regulate neuroinflammatory response. Additionally, the gut microbiota limits systemic inflammation during neurotrophic viral CNS infection by priming tonic type I interferon signaling, indicating a protective role for certain microbial signals in modulating GO:0150078.
From positive regulation of neuroinflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TBK1 required for microglial lipid droplet accumulation? | TBK1 knockout microglia |
| Does a specific UNC93B1 variant drive TLR-mediated autoimmunity? | UNC93B1 point-mutation knock-in |
| Can JAK/STAT suppression reduce neuroinflammation in vivo? | JAK/STAT knockout or pharmacological inhibition in Parkinson's models |
| Does S100A9 mediate gut-to-brain inflammatory signaling? | S100A9 knockout mice with DSS colitis |
| Does sulfatide deficiency cause neuroinflammation? | Knockout of sulfatide synthesis enzymes |
| Can PPARgamma activation suppress NF-kB-driven neuroinflammation? | PPARgamma overexpression or agonist treatment |
How to Study the positive regulation of neuroinflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptomic changes | Identify neuroinflammatory gene signatures |
| Phosphoproteomics | Kinase activation states | Map TBK1/TAK1/JAK/STAT signaling |
| Immunofluorescence | Protein localization and glial activation | Visualize microglial lipid droplets and pyroptosis |
| CRISPR knockout screening | Gene requirement for neuroinflammation | Discover novel positive regulators |
| Cytokine ELISA | Secreted proinflammatory cytokines | Quantify TNF-alpha, IL-6, IL-1beta |
| Flow cytometry | Immune cell infiltration and activation | Assess peripheral immune cell recruitment |
| Behavioral tests | Cognitive and motor function | Link neuroinflammation to functional outcomes |
Transcriptomic profiling of neuroinflammatory genes
RNA-seq and targeted gene expression panels can quantify changes in proinflammatory cytokines, chemokines, and glial activation markers following genetic or pharmacological perturbation of candidate regulators of GO:0150078. These methods help identify which genes are positively regulated downstream of TBK1, TAK1, JAK/STAT, or NF-kB.
Proteomic and phosphoproteomic analysis of signaling cascades
Mass spectrometry-based proteomics and phosphoproteomics can map the activation states of kinases such as TBK1 and TAK1, and transcription factors like STAT and NF-kB, providing mechanistic insight into positive regulation of neuroinflammatory response.
Imaging of glial activation and lipid droplets
Immunofluorescence and live-cell imaging can visualize microglial activation markers, lipid droplet accumulation, and neuronal pyroptosis in models of neuroinflammation. These approaches are useful to confirm that candidate genes positively regulate neuroinflammatory phenotypes.
CRISPR-based functional screens
Pooled CRISPR knockout or activation screens can identify novel positive regulators of neuroinflammatory response in microglia or astrocytes, followed by validation with single-gene knockouts or overexpression. Such screens are powerful for discovering genes that modulate GO:0150078.
How CRISPR Can Be Used to Study GO:0150078 positive regulation of neuroinflammatory response
Knockout
CRISPR knockout of candidate genes such as TBK1, TAK1, or JAK/STAT components can determine whether they are required for positive regulation of neuroinflammatory response. For example, TBK1 knockout would test its role in ACSL1-mediated lipid droplet accumulation and neuroinflammation, while TAK1 knockout can assess neuronal pyroptosis after subarachnoid hemorrhage.
Point Mutation
Point mutations can model disease-associated variants, such as UNC93B1 variants that drive TLR-mediated autoimmunity. CRISPR point-mutation knock-in allows precise interrogation of how specific amino acid changes alter positive regulation of neuroinflammatory response.
Knock-in
Knock-in of reporter tags or disease-relevant alleles can track neuroinflammatory signaling in real time. For instance, tagging endogenous STAT or NF-kB subunits enables monitoring of their activation dynamics in response to inflammatory stimuli.
Overexpression
CRISPR-mediated overexpression of genes such as PPARgamma can test whether increasing their activity suppresses NF-kB-driven neuroinflammation. Conversely, overexpression of TBK1 or ACSL1 can amplify neuroinflammatory phenotypes for mechanistic studies.
How EDITGENE Supports positive regulation of neuroinflammatory response Research
Researchers studying positive regulation of neuroinflammatory response-related genes often need to determine whether a candidate gene is causally involved in activating or amplifying neuroinflammation. EDITGENE provides comprehensive CRISPR gene editing services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional validation of genes linked to GO:0150078.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of neuroinflammatory response research.
Frequently Asked Questions About positive regulation of neuroinflammatory response
What is GO:0150078 positive regulation of neuroinflammatory response?
GO:0150078 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of the neuroinflammatory response.
What genes are involved in positive regulation of neuroinflammatory response?
Key genes include TBK1, ACSL1, TAK1, UNC93B1, JAK, STAT, NF-kB, PPARgamma, and S100A9, as shown in studies of Parkinson's disease, Alzheimer's disease, and CNS injury.
How is positive regulation of neuroinflammatory response studied?
Researchers use RNA-seq, proteomics, imaging, and CRISPR knockout or overexpression models to measure changes in neuroinflammatory markers and signaling pathways.
What diseases are associated with positive regulation of neuroinflammatory response?
Parkinson's disease, Alzheimer's disease, subarachnoid hemorrhage, and systemic inflammation-associated neuropathology are linked to this process.
What is the role of TBK1 in neuroinflammation?
Activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation and neuroinflammation in Parkinson's disease.
How does JAK/STAT signaling regulate neuroinflammation?
Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease, indicating a positive regulatory role.
Can gut microbiota influence neuroinflammatory response?
Yes, the gut microbiota limits systemic inflammation during neurotrophic viral CNS infection by priming tonic type I interferon signaling.
What is the link between S100A9 and brain inflammation?
DSS-induced colon inflammation drives a proinflammatory signature in the brain that is ameliorated by the S100A9 inhibitor paquinimod.
How does sulfatide deficiency cause neuroinflammation?
Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.
What CRISPR models are available to study GO:0150078?
EDITGENE offers knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics services for neuroinflammation research.
Conclusion
GO:0150078 positive regulation of neuroinflammatory response is a critical biological process that underlies the amplification of CNS inflammation in neurodegenerative and acute neurological diseases. The cited literature demonstrates that kinases such as TBK1 and TAK1, transcription factors like NF-kB and STAT, and mediators such as S100A9 and sulfatide play central roles in positively regulating neuroinflammation. Understanding these mechanisms offers opportunities for therapeutic intervention. CRISPR-based models are indispensable for establishing causal relationships between candidate genes and GO:0150078. EDITGENE provides comprehensive gene editing and screening services to accelerate discovery in this field, enabling researchers to move from correlation to causation with confidence.
References
- 1. Cho HW et al.. 2025. The gut microbiota limits systemic inflammation during neurotrophic viral CNS infection by priming tonic type I interferon signaling.. J Neuroinflammation 22(1):259 PMID: 41189008
- 2. Han C et al.. 2025. Activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation and neuroinflammation in Parkinson's disease.. J Neuroinflammation 22(1):190 PMID: 40684214
- 3. Hou J et al.. 2024. Chuanxiong Renshen Decoction Inhibits Alzheimer's Disease Neuroinflammation by Regulating PPARγ/NF-κB Pathway.. Drug Des Devel Ther 18:3209-3232 PMID: 39071817
- 4. Qiu S et al.. 2021. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.. Mol Neurodegener 16(1):64 PMID: 34526055
- 5. Xu P et al.. 2021. TAK1 mediates neuronal pyroptosis in early brain injury after subarachnoid hemorrhage.. J Neuroinflammation 18(1):188 PMID: 34461942
- 6. Rael VE et al.. 2024. Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans.. J Exp Med 221(8) PMID: 38780621
- 7. Hong H et al.. 2024. Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease.. J Neuroinflammation 21(1):216 PMID: 39218899
- 8. Talley S et al.. 2021. DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod.. J Neuroinflammation 18(1):263 PMID: 34758843
